載入...
Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative
PURPOSE: We initiated a personalized medicine program in the context of early clinical trials, using targeted agents matched with tumor molecular aberrations. Herein, we report our observations. PATIENT AND METHODS: Patients with advanced cancer were treated in the Clinical Center for Targeted Thera...
Na minha lista:
| 發表在: | Clin Cancer Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4454458/ https://ncbi.nlm.nih.gov/pubmed/22966018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-1627 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|